Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_assertion type Assertion NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_head.
- NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_provenance.
- NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_assertion evidence source_evidence_literature NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_provenance.
- NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_assertion SIO_000772 22660274 NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_provenance.
- NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_assertion wasDerivedFrom befree-20150227 NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_provenance.
- NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_assertion wasGeneratedBy ECO_0000203 NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_provenance.